Peter S. Roddy
Keine laufenden Positionen mehr
Karriereverlauf von Peter S. Roddy
Ehemalige bekannte Positionen von Peter S. Roddy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CYTOKINETICS, INCORPORATED | Comptroller/Controller/Auditor | 03.04.2017 | 15.05.2019 |
| CASSAVA SCIENCES, INC. | Finanzdirektor/CFO | 01.11.2002 | 09.03.2017 |
| ASPIRA WOMEN'S HEALTH INC. | Direktor/Vorstandsmitglied | 01.02.2010 | 16.06.2016 |
| Independent Dir/Board Member | 01.02.2010 | 16.06.2016 | |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Finanzdirektor/CFO | 01.01.2002 | 01.01.2012 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Direktor/Vorstandsmitglied | 22.10.2010 | - |
Ausbildung von Peter S. Roddy
| University of California, Berkeley | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Director of Finance/CFO | 2 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CASSAVA SCIENCES, INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
- Börse
- Insiders
- Peter S. Roddy
- Erfahrung
